OncoDiag Alternatives & Competitors

12 companies similar to OncoDiag — Innovative Solutions for Cancer Diagnostics

Madison Vaccines

Developing innovative vaccines for prostate cancer patients and a test to determine their...

Venture round $15.81M

Biotechnology Health Care +1

Capio Biosciences

4 Series A $2.90M

Madison, United States

Biotechnology Health Care

MultiplexDX International

Eliminating cancer misdiagnosis by launching a new diagnostic test in 2023 and operating a...

37 Grant $1.20M

Rockville, United States

Biotechnology Health Care +1

Agensys

Pioneering advanced treatments for cancer with innovative therapeutic antibodies and drug...

Series D $106.40M

Biotechnology Health Care +1

Track all OncoDiag competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Elphogene, s.r.o.

Společnost poskytuje unikátní molekulární test oncoMonitor™ pro sledování průběhu a léčby...

6 Seed $500.00K

Czech Republic

Biotechnology Health Care +1

Theoria Science

Specializing in exosome research, pioneering cancer diagnostics and treatments, and excell...

Venture round

Biotechnology Care Economy +1

Biodesix, Inc.

Leading Diagnostic Solutions Company | Nasdaq: BDSX | 2026 & 2025 & 2024 Top Workplaces Aw...

356 Post-IPO Equity $312.49M

Louisville, United States

Biotechnology Health Care

Nouscom

57 Series C $128.50M

Switzerland

Biotechnology Health Care +1

PrognosDx Health

Pioneering the future of cancer diagnostics through advanced epigenetic testing and innova...

2-10 Debt Financing $10.00K

Palo Alto, United States

Biotechnology Health Care +1

Agendia

MammaPrint® + BluePrint® provides you with actionable insights throughout your patient’s b...

209 Private Equity $176.05M

Irvine, United States

Biotechnology Health Care +1

Avenzo Therapeutics

Developing the next generation of oncology therapies for patients

61 $661.00M

San Diego, United States

Biotechnology Health Care +1

Rarity Bioscience

Ultra-sensitive and multiplex nucleic acid assays for fast and cost efficient mutation det...

18 Seed $3.00M

Uppsala, Sweden

Biotechnology Health Care

About OncoDiag

OncoDiag is a biotech startup founded in 2012, offering innovative solutions for cancer diagnostics. The company focuses on the development and commercialization of solutions for the detection, diagnosis, and monitoring of cancers, with a priority on bladder, colorectal, and prostate cancer. With its recent €2.50M Seri...

Taxonomy

Cancer Diagnostics, Medical Innovation, Oncology, Bladder Cancer, Colorectal Cancer, Prostate Cancer, Molecular Tools, Public Health, Biotech Startup, Clinical Research, Medical Monitoring, Sensitivity And Specificity

Frequently Asked Questions

Companies similar to OncoDiag include Madison Vaccines, Capio Biosciences, MultiplexDX International, Agensys, Elphogene, s.r.o.. They work in Biotechnology and Health Care and share OncoDiag's focus on oncology, cancer diagnostics and prostate cancer.

Bounce Watch lists 12 companies that share OncoDiag's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches OncoDiag and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

OncoDiag Profile Madison Vaccines Alternatives Capio Biosciences Alternatives MultiplexDX International Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at OncoDiag on 12 Sep 2024. The 12 companies listed here were last checked between 25 Jul 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.